TRANCE/TNFSF11/RANK L Antibodies
We offer TRANCE/TNFSF11/RANK L Antibodies for use in common research applications: Chromatin Immunoprecipitation (ChIP), Dot Blot, ELISA, ELISA Capture (Matched Antibody Pair), ELISA Detection (Matched Antibody Pair), ELISA Standard (Matched Pair), Flow (Cell Surface), Flow Cytometry, Flow Cytometry (Negative), Immunocytochemistry/Immunofluorescence, Immunohistochemistry, Immunohistochemistry-Frozen, Immunohistochemistry-Paraffin, Immunoprecipitation, Immunoprecipitation (Negative), Neutralization, Sandwich ELISA, Western Blot. Each TRANCE/TNFSF11/RANK L Antibody is fully covered by our Guarantee+, to give you complete peace of mind and the support when you need it. Our TRANCE/TNFSF11/RANK L Antibodies can be used in a variety of model species: Human, Mouse, Rat. Use the list below to choose the TRANCE/TNFSF11/RANK L Antibody which is most appropriate for your research; you can click on each one to view full technical details, images, references, reviews and related products. Choose from our TRANCE/TNFSF11/RANK L polyclonal antibodies and browse our TRANCE/TNFSF11/RANK L monoclonal antibody catalog.
Alternate Names for TRANCE/TNFSF11/RANK L Antibodies
anti-TRANCE/TNFSF11/RANK L antibody, anti-TNFSF11 antibody, anti-CD254 antibody, anti-CD254 antigen antibody, anti-OPGLOPTB2 antibody, anti-Osteoclast differentiation factor antibody, anti-Osteoprotegerin ligand antibody, anti-RANKLreceptor activator of nuclear factor kappa B ligand antibody, anti-Receptor activator of nuclear factor kappa-B ligand antibody, anti-sOdf antibody, anti-TNF-related activation-induced cytokine antibody, anti-TRANCEODFhRANKL2 antibody, anti-tumor necrosis factor (ligand) superfamily, member 11 antibody, anti-tumor necrosis factor ligand superfamily member 11 antibody
16 Results for "trance-tnfsf11-rank-l" in Primary Antibodies
![Immunohistochemistry: TRANCE/TNFSF11/RANK L Antibody (12A668) [NB100-56512] - MQDL detects EMT biomarkers in clinical prostate cancer. EMT biomarkers (EpCAM, N-Cad, and RANKL)were detected in a clinical primary prostate cancer specimen (Gleason score 6; 3+3) with documented bone metastasis. M denotes cells that completed EMT and E/M indicates cells undergoing partial EMT. 400x. Image collected and cropped by CiteAb from the following publication (//journals.plos.org/plosone/article?id=10.1371/journal.pone.0028670) licensed under a CC-BY license.](http://images.novusbio.com/fullsize/TRANCE-TNFSF11-RANK-L-Antibody-12A668-Immunohistochemistry-NB100-56512-img0019.jpg "Immunohistochemistry: TRANCE/TNFSF11/RANK L Antibody (12A668) [NB100-56512] - MQDL detects EMT biomarkers in clinical prostate cancer. EMT biomarkers (EpCAM, N-Cad, and RANKL)were detected in a clinical primary prostate cancer specimen (Gleason score 6; 3+3) with documented bone metastasis. M denotes cells that completed EMT and E/M indicates cells undergoing partial EMT. 400x. Image collected and cropped by CiteAb from the following publication (//journals.plos.org/plosone/article?id=10.1371/journal.pone.0028670) licensed under a CC-BY license."){kind=icon}
![Western Blot: TRANCE/TNFSF11/RANK L Antibody (12A668) [NB100-56512] - Analysis using Azide Free version of NB100-56512. Human lymph node lysate (35ug per lane, RIPA buffer). Band detected at ~35kDa and ~28kDa. (Expected MW of 35.5kDa according to NP_003692.1 and of 27.7kDa according to NP_143026.1)](http://images.novusbio.com/fullsize/TRANCE-TNFSF11-RANK-L-Antibody-12A668-Western-Blot-NB100-56512-img0016.jpg){kind=icon}
![Immunocytochemistry/Immunofluorescence: TRANCE/TNFSF11/RANK L Antibody (12A668) [NB100-56512] - TRANCE was detected in immersion fixed mouse splenocytes using anti-human/mouse/rat mouse monoclonal antibody (Catalog # NB100-56512) for 1 hour at room temperature. Cells were stained using NL557 (red) fluorescent anti-mouse secondary antibodies (Catalog # NL007) and counterstained with DAPI (blue).](http://images.novusbio.com/fullsize/TRANCE-TNFSF11-RANK-L-Antibody-12A668-Immunocytochemistry-Immunofluorescence-NB100-56512-img0018.jpg){kind=icon}
![Immunohistochemistry: TRANCE/TNFSF11/RANK L Antibody (12A668) [NB100-56512] - MQDL detects EMT biomarkers in clinical bone tissue specimens. A representative specimen of human prostate cancer bone metastasis co-expressed high levels of epithelial EpCAM, and mesenchymal RANKL and vimentin proteins. 400x. Image collected and cropped by CiteAb from the following publication (//journals.plos.org/plosone/article?id=10.1371/journal.pone.0028670) licensed under a CC-BY license.](http://images.novusbio.com/fullsize/TRANCE-TNFSF11-RANK-L-Antibody-12A668-Immunohistochemistry-NB100-56512-img0020.jpg){kind=icon}
![Western Blot: TRANCE/TNFSF11/RANK L Antibody (12A668) [NB100-56512] - Analysis of transfected cell lysate was probed with TRANCE/TNFSF11/RANK L antibody.](http://images.novusbio.com/fullsize/TRANCE-TNFSF11-RANK-L-Antibody-12A668-Western-Blot-NB100-56512-img0013.jpg){kind=icon}
![Immunohistochemistry-Paraffin: TRANCE/TNFSF11/RANK L Antibody (12A668) [NB100-56512] - Analysis using Azide Free version of NB100-56512. FFPE human liver stained with TRANCE/TNFSF11/RANK L antibody, peroxidase-conjugate and DAB chromogen. A 2 hr incubation at RT was used.](http://images.novusbio.com/fullsize/TRANCE-TNFSF11-RANK-L-Antibody-12A668-Immunohistochemistry-Paraffin-NB100-56512-img0014.jpg){kind=icon}
![Immunohistochemistry-Paraffin: TRANCE/TNFSF11/RANK L Antibody (12A668) [NB100-56512] - Analysis using Azide Free version of NB100-56512. FFPE human lymph node probed with TRANCE/TNFSF11/RANK L antibody.](http://images.novusbio.com/fullsize/TRANCE-TNFSF11-RANK-L-Antibody-12A668-Immunohistochemistry-Paraffin-NB100-56512-img0015.jpg){kind=icon}
![Western Blot: TRANCE/TNFSF11/RANK L Antibody (12A380) [NB100-56748] - Analysis of recombinant RANKL (partial) probed with RANKL antibody at 1 ug/ml.](http://images.novusbio.com/fullsize/TRANCE-TNFSF11-RANK-L-Antibody-12A380-Western-Blot-NB100-56748-img0002.jpg "Western Blot: TRANCE/TNFSF11/RANK L Antibody (12A380) [NB100-56748] - Analysis of recombinant RANKL (partial) probed with RANKL antibody at 1 ug/ml."){kind=icon}
![Immunohistochemistry-Paraffin: TRANCE/TNFSF11/RANK L Antibody (12A380) [NB100-56748] - Analysis of FFPE human tonsil using TRANCE (12A380) antibody at 1:50 on a Bond Rx autostainer (Leica Biosystems). The assay involved 20 minutes of heat induced antigen retrieval (HIER) using 10mM sodium citrate buffer (pH 6.0) and endogenous peroxidase quenching with peroxide block. The sections were incubated with primary antibody for 30 minutes and Bond Polymer Refine Detection (Leica Biosystems) with DAB was used for signal development followed by counterstaining with hematoxylin. Whole slide scanning and capturing of representative images was performed using Aperio AT2 (Leica Biosystems). Cytoplasmic staining was observed. Staining was performed by Histowiz.](http://images.novusbio.com/fullsize/TRANCE-TNFSF11-RANK-L-Antibody-12A380-Immunohistochemistry-Paraffin-NB100-56748-img0010.jpg){kind=icon}
![Flow Cytometry: TRANCE/TNFSF11/RANK L Antibody (12A380) [NB100-56748] - Analysis using the Alexa Fluor (R) 647 conjugate of NB100-56748. Staining of RANKL in untreated mouse splenocytes (green) and 72 hour ConA-stimulated mouse splenocytes (red) using this antibody. 1 ug of RANKL antibody was used for this assay.](http://images.novusbio.com/fullsize/TRANCE-TNFSF11-RANK-L-Antibody-12A380-Flow-Cytometry-NB100-56748-img0006.jpg){kind=icon}
![Immunohistochemistry-Frozen: TRANCE/TNFSF11/RANK L Antibody (12A380) [NB100-56748] - Analysis in RAW cells using 2 ug of antibody. Shaded histogram represents cells without antibody; green represents isotype control antibody; purple represents antibody. Image using the PE format of this antibody.](http://images.novusbio.com/fullsize/TRANCE-TNFSF11-RANK-L-Antibody-12A380-Immunohistochemistry-Frozen-NB100-56748-img0011.jpg){kind=icon}
![Flow Cytometry: TRANCE/TNFSF11/RANK L Antibody (12A380) [NB100-56748] - Analysis using the Alexa Fluor (R) 488 conjugate of NB100-56748. Staining of RANKL in untreated mouse splenocytes (green) and 72 hour ConA-stimulated mouse splenocytes (red) using this antibody. 1 ug of RANKL antibody was used for this assay.](http://images.novusbio.com/fullsize/TRANCE-TNFSF11-RANK-L-Antibody-12A380-Flow-Cytometry-NB100-56748-img0005.jpg){kind=icon}
![Western Blot: TRANCE/TNFSF11/RANK L Antibody (8A7B9) [NBP2-61813] - Analysis using TNFSF11 mAb against HEK293 (1) and TNFSF11 (AA: 74-308)-hIgGFc transfected HEK293 (2) cell lysate.](http://images.novusbio.com/fullsize/TRANCE-TNFSF11-RANK-L-Antibody-8A7B9-Western-Blot-NBP2-61813-img0006.jpg "Western Blot: TRANCE/TNFSF11/RANK L Antibody (8A7B9) [NBP2-61813] - Analysis using TNFSF11 mAb against HEK293 (1) and TNFSF11 (AA: 74-308)-hIgGFc transfected HEK293 (2) cell lysate."){kind=icon}
![Immunocytochemistry/Immunofluorescence: TRANCE/TNFSF11/RANK L Antibody (8A7B9) [NBP2-61813] - Analysis of Hela cells using TNFSF11 mouse mAb (green). Blue: DRAQ5 fluorescent DNA dye. Red: Actin filaments have been labeled with Alexa Fluor- 555 phalloidin. Goat anti-Mouse IgG (H+L) DyLight 488 secondary antibody was used.](http://images.novusbio.com/fullsize/TRANCE-TNFSF11-RANK-L-Antibody-8A7B9-Immunocytochemistry-Immunofluorescence-NBP2-61813-img0003.jpg){kind=icon}
![Immunohistochemistry-Paraffin: TRANCE/TNFSF11/RANK L Antibody (8A7B9) [NBP2-61813] - Analysis of bladder cancer tissues using TNFSF11 mouse mAb with DAB staining.](http://images.novusbio.com/fullsize/TRANCE-TNFSF11-RANK-L-Antibody-8A7B9-Immunohistochemistry-NBP2-61813-img0004.jpg){kind=icon}
![Flow Cytometry: TRANCE/TNFSF11/RANK L Antibody (8A7B9) [NBP2-61813] - Analysis of Hela cells using TNFSF11 mouse mAb (green) and negative control (red).](http://images.novusbio.com/fullsize/TRANCE-TNFSF11-RANK-L-Antibody-8A7B9-ELISA-NBP2-61813-img0002.jpg){kind=icon}
![Western Blot: TRANCE/TNFSF11/RANK L Antibody (8A7B9) [NBP2-61813] - Analysis using TNFSF11 mAb against human TNFSF11 (AA: 74-308) recombinant protein. (Expected MW is 52.6 kDa)](http://images.novusbio.com/fullsize/TRANCE-TNFSF11-RANK-L-Antibody-8A7B9-Western-Blot-NBP2-61813-img0005.jpg){kind=icon}
![Western Blot: TRANCE/TNFSF11/RANK L Antibody (8A7B9) [NBP2-61813] - Analysis using TNFSF11 mouse mAb against COS7 (1), Hela (2), U937 (3), HL-60 (4), Raji (5), Ramos (6), Jurkat (7), and SW480 (8) cell lysate.](http://images.novusbio.com/fullsize/TRANCE-TNFSF11-RANK-L-Antibody-8A7B9-Western-Blot-NBP2-61813-img0007.jpg){kind=icon}
![ELISA: TRANCE/TNFSF11/RANK L Antibody (8A7B9) [NBP2-61813] - Black line: Control Antigen (100 ng);Purple line: Antigen (10ng); Blue line: Antigen (50 ng); Red line:Antigen (100 ng)](http://images.novusbio.com/fullsize/TRANCE-TNFSF11-RANK-L-Antibody-8A7B9-ELISA-NBP2-61813-img0001.jpg){kind=icon}
![Western Blot: TRANCE/TNFSF11/RANK L Antibody - BSA Free [NB100-80849] - Rat liver tissue lysate with sRANK-L antibody at (A) 0.25 and (B) 0.5 ug/ml.](http://images.novusbio.com/fullsize/TRANCE-TNFSF11-RANK-L-Antibody---BSA-Free-Western-Blot-NB100-80849-img0011.jpg "Western Blot: TRANCE/TNFSF11/RANK L Antibody - BSA Free [NB100-80849] - Rat liver tissue lysate with sRANK-L antibody at (A) 0.25 and (B) 0.5 ug/ml."){kind=icon}
![Immunohistochemistry-Paraffin: TRANCE/TNFSF11/RANK L Antibody - BSA Free [NB100-80849] - Staining of human small intestine tissue after heat-induced antigen retrieval. Antibody concentration 5 ug/ml.](http://images.novusbio.com/fullsize/TRANCE-TNFSF11-RANK-L-Antibody---BSA-Free-Immunohistochemistry-Paraffin-NB100-80849-img0007.jpg){kind=icon}
![Immunohistochemistry-Paraffin: TRANCE/TNFSF11/RANK L Antibody - BSA Free [NB100-80849] - Staining of human breast tissue after heat-induced antigen retrieval. Antibody concentration 5 ug/ml.](http://images.novusbio.com/fullsize/TRANCE-TNFSF11-RANK-L-Antibody---BSA-Free-Immunohistochemistry-Paraffin-NB100-80849-img0005.jpg){kind=icon}
![Western Blot: TRANCE/TNFSF11/RANK L Antibody [NB100-56392] - Analysis of CD254. A. CD254 recombinant protein fragment. Note: this is not a full-length protein. B. LNCaP lysate using CD254 antibody at 0.5 ug/mL.](http://images.novusbio.com/fullsize/TRANCE-TNFSF11-RANK-L-Antibody-Western-Blot-NB100-56392-img0003.jpg "Western Blot: TRANCE/TNFSF11/RANK L Antibody [NB100-56392] - Analysis of CD254. A. CD254 recombinant protein fragment. Note: this is not a full-length protein. B. LNCaP lysate using CD254 antibody at 0.5 ug/mL."){kind=icon}
![Western Blot: TRANCE/TNFSF11/RANK L Antibody [NBP1-31140] - A. 50 ug rat lung extract 10 % SDS-PAGE RANKL antibody [C2C3], C-term dilution: 1:1000](http://images.novusbio.com/fullsize/TRANCE-TNFSF11-RANK-L-Antibody-Western-Blot-NBP1-31140-img0009.jpg "Western Blot: TRANCE/TNFSF11/RANK L Antibody [NBP1-31140] - A. 50 ug rat lung extract 10 % SDS-PAGE RANKL antibody [C2C3], C-term dilution: 1:1000"){kind=icon}
![Immunohistochemistry-Paraffin: TRANCE/TNFSF11/RANK L Antibody [NBP1-31140] - Paraffin-embedded human breast carcinoma. RANKL antibody [C2C3], C-term diluted at 1:500.](http://images.novusbio.com/fullsize/TRANCE-TNFSF11-RANK-L-Antibody-Immunohistochemistry-Paraffin-NBP1-31140-img0011.jpg){kind=icon}
![Western Blot: TRANCE/TNFSF11/RANK L Antibody [NBP1-31140] - Sample (30 ug of whole cell lysate) A: Hela 10% SDS PAGE RANKL (CD254) antibody diluted at 1:1000](http://images.novusbio.com/fullsize/TRANCE-TNFSF11-RANK-L-Antibody-Western-Blot-NBP1-31140-img0008.jpg){kind=icon}
